Gene expression patterns in myelodyplasia underline the role of apoptosis and differentiation in disease initiation and progression.
The myelodysplastic syndromes (MDS) are clonal stem cell disorders, characterized by ineffective and dysplastic hematopoiesis. The genetic and epigenetic pathways that determine disease stage and progression are largely unknown. In the current study we used gene expression microarray methodology to examine the gene expression differences between normal hematopoietic cells and hematopoietic cells from patients with MDS at different disease stages, using both unselected and CD34+ selected cells. Significant differences between normal and MDS hematopoietic cells were observed for several genes and pathways. Several genes promoting or opposing apoptosis were dysregulated in MDS cases, most notably MCL1 and EPOR. Progression from RA to RAEB(T) was associated with increased expression of several histone genes. In addition, the RAR-RXR pathway, critical for maintaining a balance between self-renewal and differentiation of hematopoietic stem cells, was found to be deregulated in hematopoietic cells from patients with advanced MDS compared to patients with refractory anemia. These findings provide new insights into the understanding of the pathophysiology and progression of MDS, and may guide to new targets for therapy. Taken together with previous published data, the present results also underscore the considerable complexity of the regulation of gene expression in MDS.
Bar
Merav
M
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Stirewalt
Derek
D
Pogosova-Agadjanyan
Era
E
Wagner
Vitas
V
Gooley
Ted
T
Abbasi
Nissa
N
Bhatia
Ravi
R
Deeg
H Joachim
HJ
Radich
Jerald
J
Exp Hematol. 2000 Jul;28(7):784-91
10907640
Br J Haematol. 1998 Oct;103(1):176-88
9792306
Br J Haematol. 2008 Feb;140(4):444-53
18162123
N Engl J Med. 1999 May 27;340(21):1649-60
10341278
N Engl J Med. 2003 Nov 20;349(21):2042-54
14627790
Leukemia. 1994 Apr;8(4):638-41
7512175
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
12883005
Leuk Lymphoma. 2000 Apr;37(3-4):405-14
10752992
Br J Haematol. 2000 Sep;110(4):876-9
11054073
Nat Rev Cancer. 2006 Jan;6(1):38-51
16397526
Int J Hematol. 2004 Aug;80(2):140-5
15481442
Acta Haematol. 2003;109(1):29-34
12486320
Gene. 2004 Mar 17;328:1-16
15019979
Nat Rev Genet. 2002 Jun;3(6):415-28
12042769
Blood. 2002 Aug 1;100(3):791-8
12130488
Cell. 2003 Nov 26;115(5):537-49
14651846
Blood. 2007 Feb 15;109(4):1620-6
17062731
Leukemia. 2003 Dec;17(12):2460-6
14562111
Haematologica. 2001 Oct;86(10):1038-45
11602409
Int J Biochem Cell Biol. 2005 Feb;37(2):267-71
15474972
Cancer Res. 2006 Jun 15;66(12):6210-8
16778195
Br J Haematol. 2004 Jun;125(5):576-83
15147372
Haematologica. 1998 Jan;83(1):71-86
9542325
Leuk Res. 1999 Mar;23(3):239-46
10071075
Clin Lab Haematol. 2006 Apr;28(2):126-9
16630218
J Exp Med. 2006 May 15;203(5):1283-93
16682494
Hematology. 2005 Aug;10(4):281-7
16085540
Stem Cells. 2004;22(4):590-9
15277704
Curr Top Microbiol Immunol. 2006;302:145-67
16620028
Int J Cancer. 2003 Nov 1;107(2):202-8
12949795
Mol Cancer Ther. 2006 Feb;5(2):356-61
16505109
Best Pract Res Clin Haematol. 2001 Sep;14(3):479-95
11640866
Genomics. 2004 Feb;83(2):321-31
14706461
Leukemia. 1995 Nov;9(11):1818-21
7475268
Blood. 2001 Sep 15;98(6):1914-21
11535529
Cell. 2003 Nov 26;115(5):508-10
14651842
Br J Haematol. 2000 Sep;110(3):584-90
10997968
Int J Hematol. 2001 Jun;73(4):429-437
11503956
Semin Hematol. 1996 Apr;33(2):127-38
8722683
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
16199517
PLoS Med. 2008 Feb;5(2):e35
18271621
Cell Signal. 2004 Oct;16(10):1085-104
15240004
Leukemia. 1994 Aug;8(8):1331-6
8057669
Blood. 2002 Feb 1;99(3):746-53
11806973
Mayo Clin Proc. 2005 May;80(5):681-98
15887439
Biochem Pharmacol. 2006 Nov 30;72(11):1563-9
16836980
Nephron. 2001 Mar;87(3):215-22
11287756
Eur J Haematol. 2006 Jan;76(1):23-32
16343268
Leuk Res. 2002 Oct;26(10):899-902
12163050
Cancer. 2004 Sep 1;101(5):989-98
15329908
Br J Haematol. 1982 Jun;51(2):189-99
6952920
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
11309499
Nucleic Acids Res. 1996 Feb 1;24(3):486-93
8602362
Blood. 2002 Nov 15;100(10):3553-60
12411319
Br J Haematol. 2003 Mar;120(6):1037-46
12648074
Br J Haematol. 1986 May;63(1):149-59
3707860
Clin Immunol. 2004 Dec;113(3):310-7
15507396
Curr Hematol Rep. 2003 Mar;2(2):122-9
12901143
Leuk Res. 2005 Feb;29(2):215-24
15607371
Blood. 2006 Jul 1;108(1):337-45
16527891
Science. 2005 Feb 18;307(5712):1101-4
15718471
Blood. 1998 Apr 15;91(8):2985-90
9531610